Waldencast plc

Waldencast plc operates in the beauty and personal care sector, offering skincare and cosmetics products across multiple geographic markets including North America, Europe, the Middle East, Asia-Pacific, and Oceania. The company manufactures and distributes dermatological skincare products designed to address aging signs, hyperpigmentation, and skin tone enhancement, alongside a broader cosmetics portfolio encompassing foundations, concealers, primers, blushes, eyeshadows, and lip color products.

The business is organized into two principal segments: Obagi Medical, which focuses on professional-grade skincare targeting physicians and dermatologists, and Milk Makeup, which operates in the mainstream cosmetics and beauty space. Waldencast distributes its products through multiple channels including medical practitioners, traditional retailers, and direct-to-consumer e-commerce platforms, as well as through third-party logistics and delivery providers.

The company operates with approximately 335 full-time employees and maintains its corporate headquarters in London. Waldencast was incorporated in 2020 and is listed on Nasdaq, with a current market capitalization of approximately $0.2 billion.